OR WAIT null SECS
BioClinica today announced that it has signed a three-year, multi-million dollar agreement for enterprise-wide EDC technology and data management services with a global, multibillion dollar division of a Top 10 pharmaceutical company. Designed for maximum efficiency and flexibility, BioClinica Express will support nearly 200 studies annually for this organization. Together the firms have developed a common data model based on CDISC standards that will facilitate rapid deployment and study closeout while supporting a challenging clinical environment.
The client chose BioClinica Express as part of a broad evaluation of all the leading solutions to achieve its goal of running paperless clinic studies. This agreement marks the second enterprise-level, fullservice EDC agreement that BioClinica has announced this year. BioClinica announced a similar agreement for BioClinica Express and data management services with Cephalon in February.
BioClinica Express is a comprehensive EDC solution that coordinates and organizes the collection and dissemination of clean data, adding speed and quality to the clinical trial process. Express will be used for direct data entry and BioClinica’s full service data management staff will assure that all data is cleaned and processed in a timely manner.